News about Global Pharma

WuXi Biologics Collaborates with VISEN Pharmaceuticals to Manufacture Lonapegsomatropin at Chengdu Microbial Manufacturing Site

WuXi Biologics and VISEN Pharmaceuticals have initiated the technology transfer for local commercial production of lonapegsomatropin in China, marking a key milestone in their strategic collaboration to advance treatment for pediatric growth hormone deficiency.

Global Pharma | 10/06/2025 | By Manvi |  190

Global Data: Trump's move to transform US pharma manufacturing raises doubts over its effectiveness

This directive, which instructs the FDA to expedite the approval process for US pharmaceutical facilities, has ignited a wave of skepticism within the industry regarding its potential effectiveness, says GlobalData.

Global Pharma | 10/06/2025 | By Darshana |  221

Glenmark Pharmaceuticals to Launch DCGI-Approved BRUKINSA in India for Treating Blood Cancers

Glenmark Pharmaceuticals has announced the upcoming launch of zanubrutinib (BRUKINSA) in India, following DCGI approval, offering a new treatment option for five types of B-cell blood cancers.

Global Pharma | 09/06/2025 | By Manvi |  424

Lupin Secures Tentative Approval from US FDA for Oxcarbazepine ER Tablets

Lupin has received tentative approval from the US FDA for its Oxcarbazepine Extended-Release Tablets in 150 mg, 300 mg, and 600 mg strengths, to be manufactured at its Nagpur facility for the treatment of partial-onset seizures.

Global Pharma | 09/06/2025 | By Manvi |  140

Spineart Launches SCARLET AC-Ti Secured Anterior Cervical Cage in US

Spineart announces the full-market launch of its SCARLET® AC-Ti secured anterior cervical cage in the United States.

Global Pharma | 09/06/2025 | By Manvi |  420

AMDI Completes Clinical Study for Fast PCR Mini Respiratory Panel

Autonomous Medical Devices Incorporated (AMDI) announced the successful completion of its multicenter clinical study supporting FDA submission of its Mini Respiratory Panel. The respiratory panel is the first test developed for its Fast PCR system.

Global Pharma | 09/06/2025 | By Manvi |  239

ZEISS CLARUS 700 Receives NMPA Approval in China, Advancing Retinal Imaging Technology

ZEISS Medical Technology announced that the CLARUS® 700 from ZEISS has received National Medical Products Administration (NMPA) approval in China, offering advanced retinal diagnostic capabilities with ultra-widefield, high-resolution images in True Color and unsurpassed quality.

Global Pharma | 06/06/2025 | By Manvi |  154

Alvotech, Dr. Reddy's Join Hands to Co-Develop Biosimilar Candidate to Keytruda (pembrolizumab)

Alvotech and Dr. Reddy's Laboratories have entered into a global collaboration to co-develop, manufacture, and commercialise a biosimilar of Keytruda (pembrolizumab), aiming to expand access to affordable cancer treatments worldwide.

Global Pharma | 05/06/2025 | By Manvi |  230

Mindset Medical Receives FDA Clearance for Contactless Vital Sign Monitoring App

Mindset Medical, Inc. announced it has received US Food and Drug Administration (FDA) 510(k) clearance for its latest contactless vital sign monitoring solution.

Global Pharma | 05/06/2025 | By Manvi |  222

Medline Announces New Prime Vendor Agreement with The Ohio State University Wexner Medical Center

As part of the agreement, Medline will provide a portfolio of medical-surgical products and supply chain optimization solutions to the health system's more than 100 facilities to support their operational efficiency and clinical delivery goals.

Global Pharma | 05/06/2025 | By Manvi